申联生物(688098.SH)：2025年预亏2000万元

Core Viewpoint - The company expects to reduce its net loss for the fiscal year 2025, indicating an improvement in financial performance compared to the previous year [1] Financial Performance - The company anticipates a net profit attributable to shareholders of approximately -20 million yuan for the fiscal year 2025, which represents a reduction in loss of about 24.74 million yuan compared to the same period last year, resulting in a year-on-year loss reduction of approximately 55% [1] - The expected net profit attributable to shareholders, excluding non-recurring gains and losses, is approximately -23.5 million yuan for the fiscal year 2025, reflecting a decrease in loss of about 24.88 million yuan compared to the previous year, leading to a year-on-year loss reduction of approximately 51% [1]